EUVIMEDEUVIMED entdecken
Validierungsstudie

Validation and diagnostic accuracy of fractal dimension as a biomarker for grading prostate cancer using data from clinical routine

Florian Michallek iD, Stephen Gordon, Simon Doran, Yasutaka Ichikawa, Hari Krishnan, Marc Dewey, Nandita M deSouza

British Journal of Radiology · 2026

DOI: 10.1093/bjr/tqag180 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift British Journal of Radiology, 2026. Verfasst von Florian Michallek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Fractals, Magnetic Resonance Imaging. Die Arbeit nennt 48 Literaturangaben. Gefördert von: NHS England grant awarded to RM Partners, Cancer Alliance for West London, hosted by the Royal Marsden Hospital NHS Foundation Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate fractal dimension (FD) as a quantitative biomarker of prostate cancer (PCa) for the International Society of Urological Pathology Grade Group (ISUP-GG) and validate its diagnostic accuracy using clinical data from multi-scanner sources.

Methods

Over a 20-month period, 153 men with biopsy-proven PCa aged 48.6-83 years (mean 67.0 ± 7.1 years; ISUP-GG 1-5 distribution: n = 2, 68, 44, 21, and 18), imaged on multiple scanners with differing fat-saturation protocols, had FD retrospectively calculated from the edge of the index lesion. Signal intensities (SI) on dynamic contrast-enhanced magnetic resonance images (DCE-MRI) were normalized to the obturator internus muscle. For reproducibility, 20 patients had repeat FD extracted by an independent observer. FD was correlated with ISUP-GG. Previously determined thresholds were applied to determine diagnostic accuracy of FD for separating ISUP-GGs.

Results

After image normalization, tumor SI values showed similar distributions between scanners. There was a significant correlation between FD and ISUP-GG (R = 0.87, P < .000001). FD was 2.17 ± 0.01 in ISUP-GG1, 2.26 ± 0.04 in ISUP-GG2, 2.34 ± 0.04 in ISUP-GG3, 2.41 ± 0.03 in ISUP-GG4, and 2.42 ± 0.04 in ISUP-GG5. In 20 randomly selected cases, mean inter-reader FD difference was −0.01, Bland-Altman limits of agreement −0.08 to +0.05. A pre-specified threshold from previous datasets of 2.31 separated ISUP-GG1-2 from 3 to 5 with 95.2% sensitivity, 92.9% specificity, and 94.1% diagnostic accuracy.

Conclusions

FD is an accurate biomarker for grading PCa using standard clinical DCE-MRI with differing fat-saturation schemes that affect SI. Advances in knowledge Fractal dimension of DCE-MRI allows for non-invasive stratification of PCa and generalizes to different MRI scanners and fat-saturation protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsFractalsMagnetic Resonance ImagingHumansMaleAgedMiddle AgedNeoplasm GradingReproducibility of ResultsAged, 80 and overRetrospective StudiesDynamic Contrast Enhanced Magnetic Resonance ImagingSensitivity and SpecificityContrast Media

Stichwörter der Autor:innen

cancerdynamic contrast-enhanced MRIfractal analysisprostatetumor grade

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, 10117, Germany.
  • Department of Urology, Epsom and St. Helier University Hospitals NHS Trust, Surrey, KT18 7EG, United Kingdom.
  • Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, SW3 6JB, United Kingdom.
  • Department of Radiology, Mie University Hospital, Tsu, 514-8507, Japan.
  • Department of Histopathology, Epsom and St. Helier University Hospitals NHS Trust, Surrey, SM5 1AA, United Kingdom.

ORCID-Profile: Florian Michallek

Förderung

  • NHS England grant awarded to RM Partners
  • Cancer Alliance for West London, hosted by the Royal Marsden Hospital NHS Foundation Trust

Zitieren

APA

Michallek, F., Gordon, S., Doran, S., Ichikawa, Y., Krishnan, H., Dewey, M., & deSouza, N. M. (2026). Validation and diagnostic accuracy of fractal dimension as a biomarker for grading prostate cancer using data from clinical routine. British Journal of Radiology. https://doi.org/10.1093/bjr/tqag180

Vancouver

Michallek F, Gordon S, Doran S, Ichikawa Y, Krishnan H, Dewey M, et al. Validation and diagnostic accuracy of fractal dimension as a biomarker for grading prostate cancer using data from clinical routine. British Journal of Radiology. 2026. doi:10.1093/bjr/tqag180

BibTeX
@article{Michallek2026,
  author = {Michallek, Florian and Gordon, Stephen and Doran, Simon and Ichikawa, Yasutaka and Krishnan, Hari and Dewey, Marc and deSouza, Nandita M},
  title = {Validation and diagnostic accuracy of fractal dimension as a biomarker for grading prostate cancer using data from clinical routine},
  journal = {British Journal of Radiology},
  year = {2026},
  doi = {10.1093/bjr/tqag180}
}
Kostenlos starten →